AWA
PLSE icon

Argo Wealth Advisory’s Pulse Biosciences PLSE Stock Holding History

Argo Wealth Advisory’s Portfolio PLSE Stock Details PLSE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$781K Hold
28,156
– – 0.43% 46
2026
Q1 		$608K Hold
28,156
– – 0.36% 45
2025
Q4 		$387K Buy
+28,156
New +$439K 0.23% 45

Other funds holding PLSE

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
PCM
Portolan Capital Management Boston, Massachusetts $2.67B AUM 169.09% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $80.2B AUM 51.53% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Argo Wealth Advisory's PLSE Position: Q2 2026 in Review

Argo Wealth Advisory held its Pulse Biosciences (PLSE) position steady in Q2 2026 at 28,156 shares worth $781K. The position accounts for 0.43% of the portfolio, ranked #46.

Argo Wealth Advisory first reported a position in PLSE in Q4 2025 and has held it in 3 quarters since. 105 funds tracked by Wall St. Rank hold PLSE as of Q2 2026.

  • Argo Wealth Advisory held 28,156 shares of Pulse Biosciences worth $781K as of Q2 2026.
  • Argo Wealth Advisory left its Pulse Biosciences share count unchanged in Q2 2026.
  • Pulse Biosciences made up 0.43% of Argo Wealth Advisory's portfolio in Q2 2026, its #46 holding.
  • Argo Wealth Advisory first reported a position in Pulse Biosciences in Q4 2025 and has held it in 3 quarters since.
  • 105 funds tracked by Wall St. Rank held Pulse Biosciences as of Q2 2026.

Based on Argo Wealth Advisory's 13F filing for Q2 2026, filed 7 Aug 2026.